Prosecution Insights
Last updated: October 24, 2026
Application No. 18/565,302

Compound and Organic Light Emitting Device Comprising Same

Non-Final OA §103
Filed
Nov 29, 2023
Priority
Jun 02, 2021 — RE 10-2021-0071681 +1 more
Examiner
KOLLIAS, ALEXANDER C
Art Unit
1786
Tech Center
1700 — Chemical & Materials Engineering
Assignee
LG Chem Ltd.
OA Round
1 (Non-Final)
43%
Grant Probability
Moderate
1-2
OA Rounds
7m
Est. Remaining
78%
With Interview

Examiner Intelligence

Grants 43% of resolved cases
43%
Career Allowance Rate
410 granted / 957 resolved
-22.2% vs TC avg
Strong +35% interview lift
Without
With
+35.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
29 currently pending
Career history
1012
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
53.6%
+13.6% vs TC avg
§102
12.7%
-27.3% vs TC avg
§112
25.3%
-14.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 957 resolved cases

Office Action

§103
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-12 are rejected under 35 U.S.C. 103 as being unpatentable over Hatakeyama et al (US 2023/0096132, cited on IDS filed on 11/27/2024 ). Regarding claim 1, Hatakeyama et al discloses the following compound (Page 114 ): PNG media_image1.png 329 406 media_image1.png Greyscale . This compound corresponds to Chemical Formula 1 of the claims: PNG media_image2.png 250 300 media_image2.png Greyscale , where: Ar1 is a thiophene ring; Ar2 is a benzene ring; R1, is either not present or a tert-butyl group, i.e. an unsubstituted C4 alkyl; and R2 and R3 are tert-butyl groups, i.e. unsubstituted C4 alkyls. The difference between the compound disclosed by the reference and that claimed is that in the compound disclosed by the reference two (2) fused R1 groups have the formula: -C(CH3)2-C-C(CH3)2-, while the claims require the formula: -O-(CH2)m-O. However, the compound is but one embodiment and attention is directed to Formula (1) ([0016]): PNG media_image3.png 240 230 media_image3.png Greyscale , where one ring A, B, or C is fused with at least one cycloalkane having 3 to 20 carbon atoms, e.g. cyclohexane, and at least one -CH2- group can be substituted with -O- ([0022] and [0122]-[0123]). Accordingly, the disclosure of the reference encompasses an embodiment where the cycloalkyl is a cyclohexane where two (2) -CH2-- groups are replaced by -O- to obtain the following fused structure: PNG media_image4.png 300 240 media_image4.png Greyscale . where two (2) adjacent R1’s fuse to form -O-(CH2)m-O- and m is two (2). While the reference fails to exemplify the presently claimed compound nor can the claimed compound be "clearly envisaged" from the reference as required to meet the standard of anticipation, nevertheless, in light of the overlap between the claimed compound and the compound disclosed by the reference, absent a showing of criticality for the presently claimed compound, it is urged that it would have been within the skill level of one of ordinary skill in the art, to use the compound which is both disclosed by the reference and encompassed within the scope of the present claims and thereby arrive at the claimed invention. Regarding claim 2, Hatakeyama et al teaches al the claim limitations as set forth above. From the discussion above, the reference discloses Formula (1-4): PNG media_image5.png 212 304 media_image5.png Greyscale . Regarding claim 3, Hatakeyama et al teaches al the claim limitations as set forth above. As discussed above, the R1’s that are present correspond to C4 alkyls and two (2) adjacent R1’s fuse to form: PNG media_image6.png 66 72 media_image6.png Greyscale . Regarding claim 4, Hatakeyama et al teaches al the claim limitations as set forth above. As discussed above, the R1’s that are present correspond to tert-butyl groups and two (2) adjacent R1’s fuse to form: PNG media_image6.png 66 72 media_image6.png Greyscale . Regarding claim 5, Hatakeyama et al teaches al the claim limitations as set forth above. As discussed above, R2 is a C2 alkyl. Regarding claim 6, Hatakeyama et al teaches al the claim limitations as set forth above. As discussed above, R2 is a tert-butyl. Regarding claim 7, Hatakeyama et al teaches al the claim limitations as set forth above. As discussed above, R3 is a C4 alkyl. Regarding claim 8, Hatakeyama et al teaches al the claim limitations as set forth above. As discussed above, R4 is a tert-butyl. Regarding claim 9, Hatakeyama et al teaches al the claim limitations as set forth above. The compound discussed above does not correspond to the recited compound: PNG media_image7.png 198 280 media_image7.png Greyscale . However, the reference discloses that in Formula 1 ([0016]): PNG media_image8.png 182 166 media_image8.png Greyscale , X1 and X2 are >N-R, where R is phenyl group substituted with alkyls such as tert-butyl and methyl groups ([0026] and [0087]-[0089]), thereby obtaining the above compound recited in the present claims. Regarding claim 10, Hatakeyama et al teaches al the claim limitations as set forth above. Additionally, the reference discloses the following organic light emitting device (Figure 1): PNG media_image9.png 353 587 media_image9.png Greyscale , where layer 102 corresponds to the recited first electrode; layer 108 corresponds to the recited second electrode opposite the first electrode (108); layers 103 to 107 correspond to the recited organic layers; and layer 105, the light emitting layer. comprises the disclosed compound as a dopant ([0052] and [0178]). Regarding claim 11, Hatakeyama et al teaches al the claim limitations as set forth above. As discussed above, the light emitting layer comprises the disclosed compound. Regarding claim 12, Hatakeyama et al teaches al the claim limitations as set forth above. From the discussion above, the reference discloses a compound corresponds to Chemical Formula 1-5: PNG media_image10.png 364 448 media_image10.png Greyscale . Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ALEXANDER C. KOLLIAS whose telephone number is (571)-270-3869. The examiner can normally be reached on Monday-Friday, 8:00AM – 5:00 PM EST. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Boyd can be reached on (571)-272-7783. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ALEXANDER C KOLLIAS/Primary Examiner, Art Unit 1786
Read full office action

Prosecution Timeline

Nov 29, 2023
Application Filed
Sep 28, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12759989
ORGANIC COMPOUND AND ORANIC LIGHT-EMITTING DIODE COMPRISING SAME BACKGROUND OF THE INVENTION
2y 6m to grant Granted Oct 13, 2026
Patent 12753195
Iridium Complex Compound, Iridium-Complex-Compound-Containing Composition, Organic Electroluminescent Element and Method for Producing Same, Organic EL Display Device, and Organic EL Illuminator
4y 1m to grant Granted Oct 06, 2026
Patent 12723193
ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
3y 1m to grant Granted Sep 01, 2026
Patent 12692436
ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
2y 2m to grant Granted Jul 28, 2026
Patent 12624061
ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS
6y 1m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
43%
Grant Probability
78%
With Interview (+35.4%)
3y 5m (~7m remaining)
Median Time to Grant
Low
PTA Risk
Based on 957 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month